These types of questions are always great to discuss. The reality is there is a risk-benefit ratio to be considered. On one hand, there is a concern for the need for lipid-lowering to prevent cardiovascular disease, and some situations are more pressing than others. A diabetic with a known card...

Great question and pertinent clinically.In our myositis clinic, we definitely have the same general approach as that endorsed by @Paul J. DeMarco when considering the risk: benefit of various lipid-lowering agents, esp. since the use of statins is absolutely contraindicated in patients with HMGCR+ n...